- Home
- MUE vs OSUR Comparison
MUE vs OSUR Comparison
Compare MUE & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUE
- OSUR
- Stock Information
- Founded
- MUE 1999
- OSUR 2000
- Country
- MUE United States
- OSUR United States
- Employees
- MUE N/A
- OSUR N/A
- Industry
- MUE Investment Bankers/Brokers/Service
- OSUR Medical/Dental Instruments
- Sector
- MUE Finance
- OSUR Health Care
- Exchange
- MUE Nasdaq
- OSUR Nasdaq
- Market Cap
- MUE 223.1M
- OSUR 260.3M
- IPO Year
- MUE N/A
- OSUR 1986
- Fundamental
- Price
- MUE $10.02
- OSUR $3.37
- Analyst Decision
- MUE
- OSUR Hold
- Analyst Count
- MUE 0
- OSUR 2
- Target Price
- MUE N/A
- OSUR $5.50
- AVG Volume (30 Days)
- MUE 62.6K
- OSUR 697.8K
- Earning Date
- MUE 01-01-0001
- OSUR 05-07-2025
- Dividend Yield
- MUE 4.09%
- OSUR N/A
- EPS Growth
- MUE N/A
- OSUR N/A
- EPS
- MUE N/A
- OSUR N/A
- Revenue
- MUE N/A
- OSUR $185,827,000.00
- Revenue This Year
- MUE N/A
- OSUR N/A
- Revenue Next Year
- MUE N/A
- OSUR $7.46
- P/E Ratio
- MUE N/A
- OSUR N/A
- Revenue Growth
- MUE N/A
- OSUR N/A
- 52 Week Low
- MUE $8.53
- OSUR $2.69
- 52 Week High
- MUE $10.17
- OSUR $6.35
- Technical
- Relative Strength Index (RSI)
- MUE 42.40
- OSUR 44.60
- Support Level
- MUE $9.94
- OSUR $3.34
- Resistance Level
- MUE $10.45
- OSUR $3.56
- Average True Range (ATR)
- MUE 0.12
- OSUR 0.16
- MACD
- MUE -0.01
- OSUR 0.01
- Stochastic Oscillator
- MUE 19.44
- OSUR 4.49
About MUE Blackrock MuniHoldings Quality Fund II Inc.
BlackRock MuniHoldings Quality Fund II Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. The fund seeks to achieve its investment objective by investing in long-term, investment-grade municipal obligations exempt from U.S. federal income taxes.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.